Argentina Liquid Biopsy Market Size & Outlook, 2023-2030
Argentina liquid biopsy market, 2018-2030 (US$M)
Related Markets
Argentina liquid biopsy market highlights
- The Argentina liquid biopsy market generated a revenue of USD 33.5 million in 2023 and is expected to reach USD 75.9 million by 2030.
- The Argentina market is expected to grow at a CAGR of 12.4% from 2024 to 2030.
- In terms of segment, blood sample was the largest revenue generating type in 2023.
- Blood Sample is the most lucrative type segment registering the fastest growth during the forecast period.
Liquid biopsy market data book summary
| Market revenue in 2023 | USD 33.5 million |
| Market revenue in 2030 | USD 75.9 million |
| Growth rate | 12.4% (CAGR from 2023 to 2030) |
| Largest segment | Blood sample |
| Fastest growing segment | Blood Sample |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Blood Sample |
| Key market players worldwide | ANGLE PLC, Guardant Health Inc, Myriad Genetics Inc, Biocept Inc, Lucence Health, Roche, Qiagen NV, Illumina Inc, Thermo Fisher Scientific Inc, Epigenomics AG, Oncimmune, Freenome |
Other key industry trends
- In terms of revenue, Argentina accounted for 0.3% of the global liquid biopsy market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil liquid biopsy market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 135.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Liquid Biopsy Market Scope
Liquid Biopsy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Argentina liquid biopsy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to liquid biopsy market will help companies and investors design strategic landscapes.
Blood sample was the largest segment with a revenue share of 73.13% in 2023. Horizon Databook has segmented the Argentina liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to 2030.
Initially, the test would be made available for research use only until it gets regulatory authorization from the respective countries. In addition, the country has a high burden of cancer, and its rising prevalence is propelling the demand for cancer screening tests.
A regional hub for Latin America has been established at the National Cancer Institute of Argentina (Instituto Nacional del Cáncer de Argentina) to enhance and promote related activities in the region.
However, the socioeconomic barriers are high in the country, along with limited healthcare facilities that can provide these tests. Thus, increasing the turnaround time required due to export of samples to central laboratories in other countries.
Reasons to subscribe to Argentina liquid biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Argentina liquid biopsy market databook
-
Our clientele includes a mix of liquid biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina liquid biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Argentina liquid biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Argentina liquid biopsy market size, by type, 2018-2030 (US$M)
Argentina Liquid Biopsy Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
